|
|
|
|
|
|
|
|
|
|
Join the CRO Solutions Expo: Finding the Right Partner for Early-Stage Oncology Trials on Nov. 19, 2025. In just 2 hours, hear 15-minute presentations from leading CROs, compare Phase 1 & 2 oncology capabilities, and engage in live Q&A. Designed for clinical ops leaders, procurement teams, and oncology sponsors, this event helps you build a curated shortlist of CRO partners—faster, smarter, and without travel. Featuring insights from Clin.AI on CRO selection success.
|
|
|
|
|
|
Webinar | IQVIA Technologies
|
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.
|
|
|
|
|
|
Video | Clinical Leader
|
In this clip, Dr. Jessica Brecher of Tectonic Therapeutic reveals why many trial sites refuse to activate sexual-orientation and gender-identity (SOGI) questions — from investigator discomfort to patient fears — and why collecting these data is scientifically essential.
|
|
|
|
|
|
Video | Castor
|
Built on interoperability, intelligence, and regulatory rigor, Castor Catalyst provides the infrastructure to connect, the automation to scale, and the expertise to turn complex data into actionable evidence.
|
|
|
|
|
|
Video | OpenClinica
|
Recruitment too often causes delays, extra costs, and underpowered studies. By reaching more people, across more conditions, in half the time and cost, we make participant enrollment more of a breakthrough.
|
|
|
|
|
|
Video | Signant Health
|
Recruitment delays putting your drug supply at risk? Without real-time visibility into enrollment rates, site performance, and supply levels, it is nearly impossible to proactively manage risk and optimize your trials.
|
|
|
|
|
|
Webinar | Citeline
|
Explore what this next phase of evolution means for clinical trial planning and execution, and examine how innovative approaches are reshaping recruitment strategies from the ground up.
|
|
|
